Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2024-05-20 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
2023年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2023 Annual General Meeting (AGM) of Tian Kang Biological Co., Ltd. It includes voting results on various proposals such as the 2023 Annual Report, Board and Supervisory Board work reports, financial reports, profit distribution plans, and other corporate matters. The document also mentions the meeting date, attendance, voting methods, and legal opinions confirming the validity of the meeting and resolutions. There is no full financial report or detailed financial statements included, but rather the announcement of the voting results and resolutions passed at the AGM. This fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4347 characters, which is sufficient to contain detailed voting results and resolutions, not just a brief announcement or a report publication notice. Therefore, the correct classification is DVA with high confidence.
2024-05-20 Chinese
关于天康生物股份有限公司2023年年度股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2023 Annual General Meeting (AGM) of Tian Kang Bio Co., Ltd. It details the legality of the meeting's convening, attendance, voting procedures, and results. The document includes specific voting results on various agenda items from the 2023 AGM. The document is not the AGM presentation materials themselves but a legal opinion on the AGM process and results. Given the content and purpose, this document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results and legality of the AGM proceedings. The document length is under 5,000 characters, but it contains detailed voting results and legal opinions, not just an announcement of a report publication, so it is not an RPA. Therefore, the classification is DVA with high confidence.
2024-05-20 Chinese
关于2024年4月份生猪销售简报
Regulatory Filings Classification · 95% confidence The document is a sales brief for April 2024 from Tian Kang Biological Co., Ltd., detailing monthly sales volume, revenue, and prices of live pigs. It includes a risk warning and clarifies that the data is unaudited and only represents one business segment. The document is short (1699 characters) and does not contain comprehensive financial statements or detailed analysis typical of quarterly or annual reports. It is a periodic sales update rather than a full financial report or earnings release. It is not an announcement of a report publication but a standalone brief. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-05-09 Chinese
2024年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "天康生物股份有限公司2024 年第一季度报告" which translates to "Tiankang Biological Co., Ltd. 2024 First Quarter Report." It contains detailed financial data including balance sheets, income statements, cash flow statements, and notes on financial performance for the first quarter of 2024. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the quarter ending March 31, 2024. It is not an announcement of a report but the report itself, and it is unaudited as noted. This matches the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-04-29 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a company's board meeting, including election of a new chairman and committee members, and approval of the company's 2024 first quarter report. It includes voting results and references to compliance with company law and governance standards. The document does not contain the full quarterly report itself but mentions that the detailed quarterly report is published separately (announcement number 2024-036). The document is short (1195 characters) and serves as a meeting resolution announcement rather than a full financial report. Therefore, it fits best under Board/Management Information (MANG) as it announces changes in the board and management positions and related resolutions.
2024-04-29 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolution passed at the eighth supervisory board's ninth (extraordinary) meeting of Tiankang Bio Co., Ltd. It specifically mentions the approval of the company's 2024 first quarter report and states that the report content is true, accurate, and complete. However, the document itself does not contain the actual financial data or the full quarterly report; instead, it references where the full report can be found (in a newspaper and on a website) and provides the announcement number for that report. The document length is short (744 characters), and it serves as a notice of the supervisory board's approval of the quarterly report rather than the report itself. According to the MENU VS MEAL RULE, this is an announcement related to the report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement about the approval of a report rather than the report itself.
2024-04-29 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.